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Abstract  
The requirement for DNA evidence in forensics has increased, meaning the demand for 
DNA typing has also increased. Current analytical processes for DNA evidence are known to be 
costly and time-consuming and traditionally occur at a centralised laboratory which can impact 
on the amount of time from sample collection to DNA profile generation. Therefore, research 
has focused on creating technologies that are capable of in-field analysis. Oxford Nanopore 
Technologies developed MinIONÔ, a portable, cost-effective nanopore sequencer that is 
capable of in-field analysis. The development of in-field sequencing technologies is favourable 
for isolated and remote communities where traditional laboratory environments are not 
feasible. Furthermore, the development of these processes is favourable as backlogs and costs 
with traditional methods can be reduced. In-field sequencing also has the potential to be used 
in a range of disciplines including personal healthcare, pathogen identification and disaster 
victim identification. With the advancement of sequencing technologies research has also 
focused on how to increase the discriminatory power of DNA typing with the selection of 
alternative markers specific for human identification. This review will investigate current 
sequencing technologies and techniques as well as evaluating current targets for DNA analysis. 
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1 Introduction 
The analysis of short tandem repeats (STRs) is the current standard for forensic DNA 
analysis and human identification (1-4). The analysis involves the extraction and quantification 
of DNA from forensic evidence, followed by PCR amplification of STRs and allele detection with 
capillary electrophoresis (CE) (3). This process is known to be time-consuming and costly, with 
specially trained individuals required to operate the machinery and interpret the results from 
a centralised laboratory environment (3, 5, 6). With increased reliance on DNA evidence, the 
demand for DNA analysis has increased; as a result, processing backlogs have been created (5). 
Furthermore, the costs associated with current processes have seen restrictions applied to the 
number of samples that can undergo DNA typing; therefore, DNA evidence may be overlooked 
by investigators (2). Research and industry are now looking towards rapid in-field DNA 
sequencing technologies, which will allow DNA sequencing to occur in-field at the scene, 
meaning less samples are transported to centralised laboratories alleviating pressures and 
backlogs currently experienced by traditional sequencing methods (2, 7).  
Recent technological advances, including automation and direct PCR analysis along with 
the development of next-generation sequencing (NGS) technologies, have made rapid in-field 
DNA sequencing feasible (2). Several rapid DNA sequencing platforms have been developed, 
such as RapidHIT (Integen) (8-10), DNAScan/ANDE (11, 12) and ParaDNA (LGC) (1, 2, 13). 
Oxford Nanopore Technologies (ONT) have released their Oxford Nanopore MinIONÔ 
sequencer. The MinIONÔ system utilises nanopores to provide real-time sequencing results 
with simple library preparation (15). The development of in-field techniques has the potential 
to reduce current backlogs, as time pressures will be alleviated and transport costs reduced 
(5). Development of in-field sequencing is favourable for remote and isolated environments 
where centralised laboratories are not feasible (16). In-field sequencing has the potential to be 
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used for human identification during military operations, at border crossings and airports as 
well as victim identification following mass disasters, and infectious disease diagnosis (14, 17).  
As degradation can limit STR analysis and forensic samples are often degraded, or of low 
quality, STR typing may not always be useful for forensic DNA analysis (5, 18). Current 
commercially available STR typing kits generate amplicons of 100 – 450 base pairs (bp), which 
are not always favourable for analysis of forensic DNA samples. The literature suggests that by 
moving PCR primers closer to the STR regions to reduce amplicon size, producing miniSTRs, a 
higher success rate for forensic DNA typing may be achieved (3, 19). An alternative to STRs are 
single nucleotide polymorphism (SNPs) due to their ability to target degraded DNA; however, 
they do not exhibit the same discrimination power as STRs (20, 21). Alternatively, the analysis 
of mitochondrial DNA (mtDNA) can also prove useful for identification purposes (22). Currently 
forensic databases utilise STR data, it is unlikely that SNPs or mtDNA analysis would replace 
STRs for forensic identification; however, there is a consensus that these regions can be a 
useful addition to current analysis processes and will therefore be considered (21, 23).  
This review will investigate in-field sequencing technologies for human identification. The 
aim is that this will direct future research for in-field sequencing technologies so that these 
methods can undergo validation for use in forensic processes, which will subsequently see 
backlogs and costs with traditional methods reduced.  
2 Discussion 
2.1 Forensic DNA Analysis  
The human genome contains regions of genetic variation, the most common forms of 
variation are length or sequence variation (17, 24). Genetic variation differs between 
individuals, it is this variation that is investigated for forensic DNA analysis and human 
identification (17). Currently the analysis of STR regions are the standard for forensic DNA 
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typing (17). While this is the current standard, the future of DNA typing is always being 
explored (17). Recently SNPs have been investigated for their ability to be incorporated to 
forensic DNA investigations (18). Similarly, the analysis of mtDNA has also been proposed (22). 
These regions will be described and reviewed in subsequent sections.  
2.1.1 Short Tandem Repeats  
STRs, are repeating units comprised of 1 – 6 bp that total approximately 3% of the 
human genome (25). STRs have a high mutation rate, due to this they contribute to a large 
proportion of human genetic variation (25). As such, STR typing is the most commonly utilised 
method for forensic identification (4). In 1997, the FBI established a core set of 13 loci for 
human identification; these loci formed the combined DNA identification system (CODIS). The 
included loci are; D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D21S11, 
CSF1PO, FGA, TH01, TPOX, and vWA (26). Other governments mirrored this approach, with 
core loci sets established in the European Union (EU), United Kingdom (UK) and Australia (26) 
(Appendix). 
STR typing consists of PCR, followed by size separation and allele detection by CE; this 
process is well described, with many STR typing kits commercially available (5). Current STR 
kits generate amplicon sizes ranging from 100 – 450 (bp), which often prove unsuitable for 
forensic samples (25). STR typing is limited by degradation, as forensic samples are often 
degraded or of low quantity, STR analysis often yields limited or no results (25, 27). For 
successful PCR amplification of STR regions, the template must be intact where the primers 
bind, as well as between the primer binding sites for a complete extension to occur. If this does 
not occur larger loci, such as D18S51, FGA, CSF1P0 and Penta D are the first loci likely to drop 
out and fail to amplify, reducing the discrimination power of the final identification (3). 
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Therefore, it is proposed and demonstrated in the literature that the efficiency of typing 
degraded DNA could increase by selecting primers that are closer to the repeat region, 
reducing the amplicon size to generate miniSTRs (3, 19, 25, 28). This method is favourable as 
it allows continuity with current forensic analysis processes and databasing which utilise data 
from the analysis of STR markers (3, 29).  
2.1.2 Single Nucleotide Polymorphisms  
SNPs are the most common type of polymorphism in the human genome (30). 
However, the literature debates the role of SNPs in forensics, with conjecture as to whether 
SNPs will replace STRs as the primary form of human identification (30). SNPs are favourable 
as they utilise short amplicons, which are useful for the analysis of degraded samples (31, 32). 
The disadvantage is that SNPs are bi-allelic and have a lower mutation rate than STRs; 
therefore, to gain the same discrimination power as STR typing approximately 50 SNPs are 
required (4, 17). Additionally, existing databases do not utilise SNP data; therefore, it is unlikely 
that they will completely replace STRs (20, 32, 33). There is, however, a consensus that the 
investigation of SNPs should continue as they may be a useful addition to STR typing 
procedures for human identification (21, 33, 34). There are four forensically relevant 
categories of SNPs; identity informative, lineage informative, ancestry informative and 
phenotypic informative; and are reviewed in detail by Budowle and Daal (35), this review will 
focus on identity informative SNPs. 
SNPs for identity should have high heterozygosity to maximise the information 
available at each SNP and a low FST value to minimise chance effects between populations (35, 
36). Multiple attempts have been made to develop an identity specific SNP panel (4, 31-33). 
Kidd, and Pakstis (36) developed a panel of 19 SNPs (Appendix) that met the criteria of an FST 
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of 0.06 or less for all 40 populations investigated. This panel was highlighted in a review by 
Budowle and Daal (35) who stated that it thoroughly addressed the criteria required to develop 
a SNP panel most valuable for identity testing. The panel has also been reviewed and adapted 
by Ludwick (37). The panel by Budowle and Daal (35) was expanded on to create a panel of 92 
SNPs specific for individual identification (38). Sanchez, and Phillips (39) generated a panel of 
52 SNPs (Appendix), referred to as the SNPforID project, with reported polymorphisms in 
European, Asian and African populations for human identification. The SNPforID panel was 
developed for standard CE analysis; however, the authors noted the ability for the panel to be 
adapted to high-throughput technologies (39). They also recommended that the described 
SNPs may be utilised in future core sets of SNPs for forensic investigations (39).  
2.1.3 Mitochondrial DNA 
The mitochondria is a single highly informative locus (haplotype) that is maternally 
inherited, has a high resistance to degradation and a high copy number compared to nuclear 
DNA (nuDNA) (40). Therefore, when the analysis of autosomal markers fails the analysis of 
mtDNA can prove useful. Human mtDNA consists of a coding region, inclusive of two ribosomal 
RNAs, 22 transfer RNAs, 13 proteins and the noncoding or control region, referred to as the 
displacement loop (D-loop) (22, 40). The D-loop is approximately 1110 bp in length; it is the 
sequence variation within this region that is of forensic value (22, 23). The sequence variation 
of the mitochondria is estimated to be 5 - 10 times greater than the nuclear genome, with 
most variation found between hypervariable region 1 (HV1) and hypervariable region 2 (HV2) 
of the control region (22, 23, 40).  
The use of mtDNA in forensics is well established (23). Analysis of mtDNA occurs by the 
determination of sequence variation by the process of PCR amplification and sequence analysis 
 14 
(35, 40). The mtDNA haplotype is recorded as differences in the universal reverence sequence 
as defined by Anderson, Bankier (41). The analysis of mtDNA is time-consuming and costly; in 
an attempt to combat this Chemale, Paneto (42) developed a SNP based screening method for 
analysis of mtDNA from forensic casework samples in Brazilian populations. The authors aimed 
to generate a process that increased discrimination, with reduced time and cost requirements 
to aid in the analysis of highly degraded samples (42). They selected 14 mtDNA SNPs located 
at the following positions; 73, 146, 152, 185, 189, 195, 16126, 16129, 16172, 16189, 16223, 
16278, 16311, and 16362 (42). The results showed full profile generation with as little as 1.0 
pg of nuDNA, furthermore; in a casework scenario for human identification, all the typed 
remains were successfully matched to their families (42). This methodology was adapted by 
Weiler, de Vries (43) for use in European populations the mtDNA SNPs used in this study were 
located at positions 73, 146, 150, 152, 182, 185, 195, 489, 497, 16126, 16129, 16223, 16270, 
16278, 16294, 16311, 16362, 16519 (43). The development of mtDNA sequence databases 
needs to be continued as this can provide useful forensically relevant information to aid in 
human identification (44). 
2.2 Sequencing History 
Frederick Sanger developed Sanger Sequencing in 1977 (45). Commonly referred to as 
first-generation sequencing this method allowed advancements within genomics; however, 
this method is limited by low throughput and high costs (46). Second-generation sequencing 
systems such as 454, SOLiDÒ and Ion TorrentÔ were developed to overcome these issues. 
Referred to as next-generation sequencing (NGS), these systems provided faster and cheaper 
results (45, 46). These systems are advantageous as they do not require bacterial cloning of 
DNA fragments like Sanger Sequencing; instead, library preparation uses a cell-free system 
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(45). However, they are limited by short read lengths, which impact on genome assembly and 
reference comparison – resulting in the introduction of third-generation sequencing 
techniques (46). Third-generation sequencing, such as nanopore sequencing, allows the 
detection of single molecules in real time without the need for PCR amplification or 
fluorescently labelled tags (37, 45). Unlike its predecessor, third-generation sequencing is 
faster and produces longer read lengths (45).  
2.2.1 Nanopore Sequencing 
David Deamer, George Church and Daniel Branton developed Nanopore sequencing 
(47). Nanopores are classified as either biological or solid state (48). Biological nanopores, or 
transmembrane protein channels, are formed when a protein becomes embedded in a 
biological membrane (48, 49). The a-Hemolysin (a-HL) exotoxin secreted by Staphylococcus 
aureus and is the most commonly used biological nanopore (50). Kasianowicz, Brandin (47) 
first published the use of a-HL for DNA translocation. The a-HL channel, is approximately 1.4 
nm in diameter, while a single-stranded DNA (ssDNA) molecule is approximately 1.3 nm in 
diameter, allowing individual nucleotides to be translocated and discriminated inside the 
nanopore (48). As biological nanopores have a constant pore size, they are limited to the 
analysis of small molecules (48).  
Solid-state nanopores are synthetically manufactured and were introduced to resolve 
the issues of their biological counterparts (48, 51). Solid-state nanopores offer superiority in 
chemical, thermal and mechanical stability as well as being adjustable in size (48, 51). Solid-
state nanopores are commonly made in silicon-based membranes, such as silicon nitride 
(Si3N4) by the process of drilling or etching (52). Nanopores have been extensively researched, 
with detailed reviews available (15, 48, 50-52).  
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2.3 In-field Sequencing Technology 
With the advancement of biological sciences and sequencing technologies the idea of 
DNA analysis occurring at a centrally based laboratory is being challenged (7). With an 
increased reliance on DNA analysis for forensic investigations, there has been an increase in 
the demand for in-field sequencing (7). Grover, and Jiang (53) describe in-field sequencing as 
rapid DNA identification and the fully automated generation and interpretation of STR profiles 
in less than two hours in a field-deployable system by non-technical users.  
The introduction of in-field systems can be beneficial, as current processes are known 
to be laborious and time-consuming (10). Several attempts have been made to reduce backlogs 
with the use of direct PCR, automation and rapid DNA technologies. Financially in-field systems 
will be beneficial as there will be a reduction in the number of samples transferred to centrally 
based laboratories, resulting in a decrease in costs associated with storage, transportation and 
staffing (7, 16). Furthermore, the idea of in-field technologies is particularly poignant for 
remote, isolated or developing regions where a centralised laboratory is not feasible and 
specially trained individuals may not be present (16). However, the introduction of in-field 
sequencing will not be without challenge as these environments are limited in their availability 
of reagents, air conditioning and internet connection (7). Despite this, the literature has shown 
the development of a range of in-field sequencing technologies. 
2.3.1 RapidHITÔ  
The RapidHITÔ 200 system from IntegenX is an automated system that generates an 
STR profile for human identification (55). The system is a self-contained portable benchtop unit 
comprised of two cartridges with a total of eight chambers (56). These chambers run 
simultaneously to analyse five samples with the remaining chambers reserved for positive and 
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negative controls as well as an allelic ladder (56). The system performs cell lysis, DNA isolation, 
STR amplification, fluorescent detection and size separation by CE within two hours (55). 
Previously validated with PowerPlex 16HS chemistry the system now utilises GlobalFiler 
(Thermo Fisher) which amplifies 21 autosomal STRs and three sex determining markers (55). 
Designed as a benchtop platform, RapidHITÔ can be transported and operated outside the 
laboratory with limited set up required; given this, homeland security and defence operations 
can have acknowledged the potential of this system (56).  
Of the published validation studies; Holland and Wendt (56) evaluated the RapidHITÔ 
system with single source samples, assessing reproducibility and contamination. The study 
found that profiles generated with RapidHITÔ were concordant with traditional methods, with 
81 of the 85 samples generating full STR profiles with no signs of contamination (56). Thong, 
and Phua (57) obtained similar results, however; they utilised blood samples, instead of buccal 
samples. While the RapidHITÔ system is transportable, it is bulky and can be impractical for 
all scenarios; this led to the development of the RapidHIT IDÔ system which was purpose-built 
for decentralised environments (8).  
The RapidHITÔ ID system is a second-generation fully automated benchtop system 
designed for non-technical users to conduct STR based human identification in approximately 
90 minutes (8-10). Validated for use with GobalFiler the profiles generated are compatible with 
CODIS. The system utilises single-use cartridges, which along with the sample can maintain 
stability for a minimum of six months when stored at 25°C (8). Along with the ability to house 
reagents in bulk for 150 uses, and the need for limited input from the user the RapidHIT IDÔ 
system is a welcome choice for in-field sequencing (8, 9).  
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2.3.2 DNAScan/ANDEÔ 
Consultation between the Federal Bureau of Investigation (FBI), Department of 
Defence and the Department of Homeland Security, highlighted the need for rapid DNA 
technologies. Subsequently, the Accelerated Nuclear DNA Equipment (ANDE) program was 
established (11). The ANDE program developed the DNAScan/ANDEÔ system, a bench top 
instrument that can generate full STR profiles from 1.0 µg of input DNA, while partial profiles 
will be generated with lower input DNA (11, 12). The system is comprised of three components; 
the BioChipSet swab, BioChipSet cassette, and the instrument itself (11). Five swabs can be 
loaded into the cassette which is pre-loaded with all required reagents, including an allelic 
ladder, an internal size standard and waste disposal (12). The cassettes have a locking cap and 
a radio frequency identification tag (RFID), so that as a swab is loaded into the cassette it is 
scanned and locked in, a security feature which eliminates the possibility that a sample can be 
removed and switched (12).  
The system also incorporates a range of subsystems; a pneumatic subsystem that 
allows reagents to be driven through the cassette, a thermal subsystem for multiplexing, a high 
voltage subsystem for electrophoresis, an optical subsystem for STR detection during 
electrophoresis and a ruggedization subsystem which allows for field transport without the 
need for calibration (11). The DNAScan/ANDEÔ system is similar to that of the RapidHITÔ 
described above, as it utilises single use cartridges, requires limited user involvement, and the 
reagents and cartridges can be stored for six months (7).  
A validation study conducted by Moreno, Brown (12) used 193 buccal swab samples 
(153 cotton and 40 flocked) to test reproducibility and repeatability of the DNAScan/ANDEÔ 
system. The results showed a 75% success rate for DNA typing when using the PowerPlex 16 
BioChip cassette (12). When substrate type was investigated flocked swabs obtained 90% 
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success rate, compared to 71% for cotton (12). Of the 1041 loci assessed, 1035 yielded 
expected results, with 4 loci showing complete drop out, while 2 loci showed partial drop out 
(12). The authors concluded that the system is robust and reliable and consistently calls correct 
DNA profiles, noting its potential to rapidly assess reference samples. Validation conducted by 
Della Manna, Nye (11) aimed to assess the system across a number of laboratories and types 
of buccal samples to assess if the generated data was compliant with FBI testing standards. 
Results showed the system was specific for human identification, with concordance to 
traditional methods reported to be 99.998% (11). 84% of samples yielded profiles in the first 
pass without human intervention, with a further 7% of profiles passed following human 
interpretation (11). Overall, the authors concluded that the system was robust and reliable as 
well as suitable for forensic human identification when used with single source buccal samples 
(11). 
2.3.3 ParaDNA  
The ParaDNA System from LGC is a portable field instrument that performs two tests; 
an intelligence test and a screening test (7). The screening test determines the amount of DNA 
in the sample by PCR analysis of D16S539 and TH01 (7); while the intelligence test generates 
an STR profile for five STR loci; D3S1358, D8S119, D16S539, D18S1358 and TH01 (7). Both tests 
profile amelogenin for sex determination (2, 7). The system contains a sampling device that is 
similar to a traditional cotton swab; the sample is collected either directly or indirectly from 
the evidence, the collector then gets loaded into the 4-well, pre-loaded PCR reaction plate (7, 
13). The system conducts PCR amplification followed by detection of allele length by DNA 
melting analysis utilising fluorescent HyBeaconâ human-specific probes in a closed tube 
system; this process takes approximately 75 minutes (1, 7).  
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Multiple studies have been conducted to validate the ParaDNA system, with high 
accuracy demonstrated with blood, saliva and semen; however, the accuracy with touch DNA 
is still speculated (2, 7). Results showed concordance with traditional sequencing methods (1, 
7). While the screening test is presumptive, it is an advantageous inclusion, as it can guide users 
on whether the sample contains DNA and can prevent investigative speculation, as well as 
reducing costs and backlogs at the processing laboratory (7).  
While all the systems described above have demonstrated concordance with 
traditional typing methods, the major disadvantage of all these systems is their ability to be 
fully portable within the field. Although developed for in-field conditions, the RapidHIT IDÔ 
and the DNAScan/ANDEÔ remain bulky and benchtop based and are therefore not always 
suitable to all in-field environments. 
2.3.4 Oxford Nanopore MinIONÔ system 
Oxford Nanopore Technologies (ONT) have exploited the a-HL nanopore to produce 
the Oxford Nanopore MinIONä sequencer (58). MinIONä is a pocket-sized, USB powered, 
real-time sequencing device (37, 59). First announced in 2012, the device became available 
through the MinIONä Access Program (MAP) in early 2014 (59). At the cost of $1000 USD, the 
system is inclusive of two flow cells and reagents (59). However, it requires the user to supply 
a computer and internet access (49). MinIONÔ sequencing works by creating a nanopore in 
an electrically resistant polymer membrane, the membrane then becomes immersed in an 
ionic solution, and a voltage is applied (49). When a molecule passes through the nanopore 
there is a characteristic disruption in the ionic current, this change is measured and is used to 
determine the identity of the molecule being translocated (4). Sequencing occurs on the flow 
cell, which contains an array of 512 sensors connected to four nanopores that are controlled 
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by an application-specific integrated circuit (60). Currently, MinIONä is the smallest 
sequencing device on the market, making it a favourable choice for in-field sequencing (49).  
2.3.4.1 Advantages and Disadvantages of MinIONÔ 
MinIONÔ has demonstrated its appeal to the sequencing community due to its low 
cost, speed and portability (50, 60). MinIONÔ is an affordable platform, as there is no 
associated instrument cost, the unit base price is $1000 USD inclusive of two flow cells, with 
additional expenses required for extra flow cells, reagents and barcoding kits (49). It also 
requires no unique installation or calibration prior to use (61) Sequencing results can be 
generated in real time, as MinIONä has a “run until” analysis feature, where the device will 
continue to analyse samples and generate data until the user stops the analysis, or to a 
maximum of 48 hours (4, 60). Therefore, generating initial sequencing results within a few 
hours of obtaining the sample. Furthermore, due to its ease of use MinIONÔ has the potential 
to be utilised by individuals untrained or unfamiliar with biological sciences, a favourable 
option for isolated or remote regions, where the availability of trained professionals may be 
limited (62). However, despite the appeal of MinIONÔ, there remain some disadvantages (62).  
Identified as one of the most significant issues with the system, the error rate of 
MinIONÔ is one of the main barriers preventing the inclusion of this technology to forensic 
science (49). While the system can obtain long read lengths, they are often inaccurate, with 
high sequencing errors. Mikheyev and Tin (15) demonstrated this when only 10% of mapped 
reads generated from sequencing an Enterobacteria phage corresponded to the known 
genome. However, ONT is continually updating the MinIONÔ system, the flow cells and 
associated products, therefore it can be expected that, in the future, this issue will be resolved, 
or better managed (49). Another disadvantage is the required input DNA; the recommended 
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input for MinIONÔ is 1000ng of DNA, which may not always be available in forensic scenarios, 
where DNA samples are often degraded (63).  
The MinIONÔ system also suffers from a time versus sensitivity trade off (64). 
Laboratory-based analysis methods differ from rapid based systems, and currently, rapid DNA 
systems will not obtain the same level of sensitivity as their laboratory-based counterparts 
(64). Mapes, Stoel (64) have considered this and identified that in a crime scene scenario Scene 
of Crime Officers (SOCO) are most likely leading the decision making and that these decisions 
are typically based on best practise and intuition. Therefore, the authors developed a 
systematic approach to decision making, referred to as a decision support system (DSS), 
between rapid or laboratory-based analysis in a crime scene environment (64). This method 
utilised the Rational Decision Theory, which suggests that there are at least two elements 
required to make a decision, in this scenario they are 1) the success rate for rapid DNA analysis 
and 2) a threshold level for the success rate for when to choose rapid DNA analysis (64). From 
this they developed four possible scenarios for the decision to use rapid DNA analysis; these 
are described in Table 1 (64). The results found that the implementation of a DSS is a beneficial 
process that can be used to guide forensic investigations as to whether they utilise rapid DNA 
analysis procedures (64). 
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Table 1. Four possible scenarios when deciding to use Rapid-DNA analysis.  
Profile Obtained No Profile Obtained 
Analyse the DNA 
sample with Rapid-
DNA and a profile is 
obtained. This 
positive result is 
obtained within 2 
hours.  
Analyse the DNA 
sample at the 
laboratory and a 
profile is obtained. 
This positive result is 
obtained within 45 
days. 
Analyse the DNA 
sample at the 
laboratory and no 
profile is obtained. 
This negative result 
is obtained in 45 
days. 
Analyse the DNA 
sample with Rapid-
DNA and no profile 
is obtained. This 
negative result is 
obtained in 2 hours.  
Table adapted from Mapes, and Stoel (64).  
 
2.3.4.2 Bioinformatic Pipelines 
With the advancement of portable sequencing technologies, the capabilities of current 
bioinformatics and analysis programs require consideration. ONT provides users with base 
calling software with the inclusion of MinKNOW, a Metrichor system that utilises a hidden 
Markov model (27). Metrichor is a cloud-based service that requires an active internet 
connection to operate (27). While MinIONÔ can produce long read length since its inception, 
there has been a trade-off between read length and high sequencing errors (15, 60, 65). To 
overcome this ONT introduced two directional (2D) reads, that read both strands of the DNA 
fragment, this was shown to reduce the error rate by about 15% from that of one directional 
(1D) reads (65). However, in 2017 2D reads were no longer supported by ONT; instead, 1D and 
1D2 reads, where two strands of the DNA molecule are delivered to the nanopore but are no 
covalently linked as seen in 2D methods, were favoured (59). Therefore, research has focused 
on improved bioinformatics, to date a range of alternative MinIONÔ specific analysis pipelines 
have been described (65-68). 
Boza, Brejova (65) developed DeepNano; a bioinformatic system that utilises a 
recurrent neural network, described by the authors as an artificial network utilised for 
sequence labelling. The authors compared DeepNano with ONT’s Metrichor and Nanocall, and 
 24 
the results showed that DeepNano 1D and 2D sequencing was the best performer with 
increased accuracy in both analyses (65). When compared to Nanonet, an experimental 
program developed by ONT, the authors found that both systems performed similarly, but 
analysis with DeepNano was faster (65).  
The development of local offline based systems will be useful for use in in-field 
environments where internet connection may be limited (60).  Subsequently, Yao, Dursi (69) 
developed Nanocall, the first offline, freely available base caller software for analysis of Oxford 
Nanopore sequencing. Unlike the Metrichor system, Nanocall only performs 1D sequencing; 
the results of this study showed that the system generated similar results to that of Metrichor 
1D analysis (69). While this system is advantageous to in-field environments, it also needs to 
be considered that individuals knowledgeable in molecular biology may not always be present 
in these areas. As a result, Shabardina, Kischka (27) developed NanoPipe, a system developed 
for users with limited bioinformatic and IT experience (27). The NanoPipe workflow comprises 
four stages; 1) data uploading, in FASTA or FASTQ formats, 2) alignment of MinIONä reads 
against the target sequence, 3) alignment analysis and 4) results (27). Following alignment, the 
system analyses nucleotide variation for each position, and a consensus sequence is generated 
along with a list of possible SNPs (27). The authors highlighted success with the system when 
used by individuals with limited bioinformatic knowledge (27).  
The research reviewed here has shown that analytical processes associated with 
MinIONÔ can be improved. Improvements here would see increased sequencing and 
alignment accuracy which would be advantageous for forensic purposes, where high accuracy 
is crucial. Furthermore, systems like Nanocall and NanoPipe are advantageous for in-field 
settings, as it is unlikely that individuals experienced in molecular biology will be present during 
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the initial analysis. However, it is evident that more research is required to improve accuracy, 
particularly if MinIONÔ is to be implemented within standard forensic practice. 
2.3.4.3 Bioinformatic Manipulation and Management 
One of the major issues associated with biological sciences is data management, there 
can be particular confusion with file formats, as they are often poorly described and 
subsequently poorly understood (70). The MinIONÔ Metrichor based analysis system uploads 
files in a FAST5 format; these files are then convertible to FASTA or FASTQ file formats (49, 59). 
FASTA and FASTQ are basic text-based file formats for the storage of nucleotide and protein 
sequences (71). FASTQ has become the standard file format for the storage of NGS data (72). 
Developed at the Wellcome Trust Sanger Institute by Jim Mullikin, FASTQ gives a numeric 
quality score to each nucleotide within the sequence in a readable ASCII format (70, 72). There 
are no set standards for the FASTQ file format, this was identified by Fields, Heuer (70) who 
aimed to create a citable definition for the FASTQ file format. The FASTQ file format (Figure 1) 
consists of four lines; an @ symbol indicates the first line; it is the title line and contains the 
record identifier (70). The second line is the sequence line containing the DNA sequence (70). 
The third line indicates the end of the sequence line and the start of the quality line, indicated 
with an + symbol; traditionally this line also includes a repeat of the title line; however, this is 
now optional and often contains only the + symbol (70). The fourth line is the quality line; the 
quality score is represented by an ASCII character that correlates to its quality value (70). This 
value is known as Phred score, which is defined by the following formula; Q = 	−10log*+Pr	(observed	allele	 ≠ true	allele),  (73) 
The Phred score is a measure of the probability that the base call is incorrect; for 
example, if Q equals 30, there would be a 0.1% error rate (73). As FASTQ is a commonly used 
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file format a range of processing tools are available that are capable of performing FASTQ data 
manipulation tasks such as quality control, reformatting, filtering, and trimming of datasets 
(72, 74). To resolve issues with data storage programs for data compression have also been 
described (75). The literature has highlighted that further development of these programs are 
required to further the information that can be obtained from sequencing data (72).  
 
(76) 
Figure 1. Structure of the FASTQ file format.  
2.3.5 MinIONÔ in In-Field Environments 
Due to the portability of MinIONä, much interest is placed on the efficiency of the 
system in in-field environments, with multiple studies conducted in a range of scientific 
disciplines to evaluate this. Research conducted by Parker, Helmstetter (77) aimed to establish 
if MinIONä could be used to identify closely related plant species in the field. The research 
aimed to extract and sequence genomic DNA within hours of collection in field-based 
environments in the Snowdonia National Park (77). The authors stated the desire to use basic 
laboratory material for DNA extraction and the desire to omit PCR amplification (77). The 
results indicated that this protocol is feasible; however, yields were less than expected, the 
authors attributed this to the developmental nature of the technology, and that given more 
research and practical application this technology can become a useful sequencing tool (77). 
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In disease outbreak situations the impact is often so vast that relying on traditional 
sequencing methods for diagnosis can be unrealistic, as those affected may have suffered 
adverse effects before sequencing results are obtained (61). Therefore, following the Ebola 
virus outbreak Quick, and Loman (78) designed a laboratory protocol utilising MinIONÔ to 
sequence the Ebola genome. They also designed a genome surveillance system to be 
transported to West Africa for use in a mobile laboratory that comprised of three MinION 
instruments, four laptops, a thermocycler, a heat block, pipettes, sufficient reagents and 
consumables (78). The entire sequencing protocol from sample collection to bioinformatics 
could be completed in 24 hours; despite the fact that enough sequence data was available 
after on hour the process was usually completed over two days (78). The authors identified 
challenges in conducting this work within in-field environments, expressing difficulties with 
mains electrics and unreliable generators, which impacted the thermocyclers (78). These 
issues did not affect MinION, which was unaffected by power outages or surges, as the system 
also handled transport well. The authors also addressed the need for offline processing (78).  
The International Space Station (ISS) is considered the most extreme environment to 
employ the MinION system for sequence analysis (16). The research aimed to sequence DNA 
extracted from a virus, bacterium and a mammal. The results obtained in the ISS were 
comparable to those obtained on the ground, as MinION was not affected by transport to the 
ISS, nor was it affected by the microgravity environment (16). Therefore, the authors 
highlighted the potential of this technology for incorporation into spaceflight for disease 
diagnosis and environmental monitoring (16). 
Finally, research conducted by Walter, and Zwirglmaier (62) utilised MinIONä in an 
inflatable tent to test effectiveness in a rapidly deployable military scenario. They found that 
the MinIONä system was favourable for in-field analysis; however, they experienced issues 
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with high temperatures and bottlenecks with data analysis (62). The authors state that on 
several occasions they had to evacuate the tent, and were required to transport the MinIONä 
in a vehicle while a cycle was running, besides some loss of reagents, they noted no adverse 
effects (62). 
2.3.6 MinIONä in Forensics 
The use of MinIONä within forensics is limited with minimal research published in the 
field. Following the release of the device in 2012 initial studies focused on understanding the 
device and the associated error rates (67, 79). Of the published research investigating 
MinIONä within forensics Michaels (80) conducted a proof of concept study to determine if 
rapid identification of human bodily fluids was probable from forensic samples by sequence 
analysis of messenger RNA (mRNA) using MinIONä. Although RNA is more susceptible to 
degradation, the study opted for RNA analysis rather than DNA, as research has shown RNA to 
be more readily detectable in forensic samples (80). The study examined semen, saliva, blood, 
vaginal fluid and menstrual blood, as current testing for these fluids is presumptive, the 
rationale was that these cells exhibit unique gene expression within the cell creating distinct 
profiles for the different fluid types; therefore, by targeting specific mRNA sequences the fluid 
type can be confirmed (80). For each body fluid investigated two genes were selected, the 
results showed that all fluids successfully identified through sequencing; however, there were 
issues with contamination from previous library preparations and gene degradation was 
evident (80). The authors stated a requirement for further development to the protocol and 
the MinIONä system as the amplicon length utilised in this study might not be adequate for 
forensic applications (80).  
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Before the release of MinIONä SNPs were analysed by single base extension; however, 
this technique was not without issue (4). Following the release of MinIONÔ Cornelis, 
Gansemans (4) conducted a proof of concept study to determine if MinIONÔ can detect SNPs 
for forensic genotyping. The study assessed 52 previously described SNPs (4). To overcome the 
minimum length requirements for MinIONÔ, the authors added an amplicon ligation protocol, 
without this only 12 of the 52 SNPs could have been analysed (4). Samples were sequenced 
over 24 hours and analysed with Metrichor 2D reads, of the 52 typed loci 51 were correct; 
however, there was a low mapping rate detected for some loci. Sequencing errors were 
associated with loci that contained homopolymer sequences; as a result, two loci (rs1493232 
and rs1031825) were considered problematic (4). Despite this, the research highlighted the 
feasibility of the MinIONÔ system for forensic SNP genotyping. This research led to the 
investigation of tri-allelic SNPs for forensic identification (81). Cornelis, Gansemans (81) 
proposed the use of tri-allelic SNPs to overcome the low discrimination power experienced by 
bi-allelic SNPs, this method is favourable as allows the analysis of DNA mixtures. This study 
identified that by examining a smaller number of tri-allelic SNPs greater coverage could be 
obtained; however, there needs to be a balance established between coverage and the quality 
of reads, which will become possible with improvements to analysis software (81). 
Research conducted by Sim and Chapman (82) aimed to conduct whole-genome 
sequencing with MinIONÔ to identify an individual in a military scenario. DNA sampling 
occurred in a mock scenario where a tempered glass KeepCup, which was known to have been 
previously used by the person of interest underwent swabbing for the collection of DNA 
evidence (82). When the forensic sample was sequenced 47.3% of reads matched to the 
Escherichia genus, with 10.3% matching to the Homo, genus, compared to the reference 
sample which exhibited a 93.7% match to the Homo genus (82). The authors attributed this to 
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the presence of environmental DNA in the forensic sample (82). Furthermore, no STR loci were 
identified; the authors stated that this was due to a low read accuracy and depth of coverage 
(82). As a result, the authors concluded that a targeted amplification approach should be 
established before sequencing to increase accuracy and the chance of identifying STR regions 
(82).  
3 Experimental Design  
The research proposed here will follow on from work conducted by Sim and Chapman 
(82). Before sequencing with MinIONÔ, a targeted PCR amplification approach will be utilised. 
While the literature has shown that STRs, SNPs and polymorphisms in the mitochondrial 
genome are useful targets for forensic DNA analysis; all of these targets have limitations (83). 
Therefore, this research will aim to generate a PCR protocol that will amplify five STRs, five 
SNPs and the mitochondrial D-loop in a single assay for increased discrimination for human 
identification in an in-field setting. Following this literature review, a selection criterion for 
these regions will be established. DNA will be collected from a volunteer by performing a buccal 
swab on the inside of their cheek. DNA will be extracted using the QIAMP DNA Investigator Kit 
(Qiagen). Following which, microfluidic methods will be used for DNA quantification. PCR 
amplification will be performed with self-designed primer sets. The DNA sequence of the PCR 
products will be interrogated with the ONT Nanopore MinIONÔ sequencer with the ligation 
flow cell. To meet the length requirements for sequencing amplicon ligation may be required. 
Data analysis will be performed to determine the STR genotype, SNP phenotype and 
mitochondrial haplotype information to determine if the unknown and known samples are 
from the same individual. The analysis will only be for comparative purposes and will not reveal 
any sensitive, identifying genetic or phenotypic information about the individual. 
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4 Aims, Objectives and Hypothesis 
4.1 Aims  
To develop a PCR protocol that selects for SNPs, STRs and the mitochondrial D-loop before 
sequence analysis with Oxford Nanopore MinIONÔ to assist in the rapid identification of an 
unknown individual to a known individual in an in-field environment. 
4.2 Objectives 
1. To investigate and identify a selection of five SNPs and five STR regions that are specific 
for human identification.   
2. Develop and design primers suitable for a multiplex PCR that will amplify the selected 
SNPs and STR regions identified during objective one as well as designing primers for 
the mitochondrial D-loop.  
3. To optimise a PCR protocol for the amplification of the selected SNPs, STR regions and 
mitochondrial D-loop. 
4. Utilise the Oxford Nanopore MinIONÔ to interrogate the unknown DNA sequence 
following PCR amplification and compare the unknown profile to a known profile for 
human identification.   
4.3 Hypothesis 
By developing a targeted PCR protocol for amplification of five STR regions, and five SNPs 
for human identification as well as the mitochondrial D-loop before sequencing with the 
Oxford Nanopore MinIONÔ, we can match a known reference sample to an unknown crime 
scene sample in an in-field environment.  
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5 Conclusion  
Forensics is a highly regulated field that is cautious to implement new technologies, 
particularly for DNA analysis; where samples are unable to be reproduced, therefore, effective 
and accurate analysis is crucial. Extensive research is required before new processes are 
implemented in standard forensic practice. MinIONÔ has the potential to become a dominant 
sequencing platform within forensic science, particularly within in-field environments. 
However, this review has highlighted issues with sequencing errors and data analysis. With 
continued technological advancement and the development of more user-friendly systems it 
is expected that these issues can be overcome. Once this occurs research can focus on 
validating the MinIONÔ system for use in forensic investigation. By continuing research in this 
field, the current pressures on standard DNA typing procedures can be reduced as DNA 
evidence can be more frequently employed for human identification in scenarios where 
forensic DNA analysis would have previously been disregarded. 
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Appendix 1. Core loci utilised by United States, European and Australian government agencies. 
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Appendix 2. SNP panel of 19 SNPs for human identification.  
 
Table adapted from Kidd, Pakstis (36). 
  
Chromosome Cytogenic 
band position 
Locus symbol ABI catalog # dbSNP rs# Nt. Position 
UCSC May 
2004 
ALFRED site 
UID 
FST 40 
Population 
FST 7 
population 
Avg. Het. 40 
population 
Avg Het. 7 
population 
4 p12 GABRA2 C_8263011_10 rs279844 46, 107, 583 S1001391O 0.0302 0.0105 0.485 0.495 
13 q32.3 PHGDHL1 C_1619935_1_ rs1058083 98,836, 234 S1001402H 0.0317 0.0135  0.464 0.484 
5 q31 SPOCK C_2556113_10 rs13182883 136, 661, 237 S1001390N 0.0333 0.0185 0.471 0.489 
1 q21.3-q22 LY9 C_1006721_1_ rs560681 157, 599, 743 S1001392P 0.0345 0.0183 0.434 0.439 
10 q26 HSPA12A C_3254784_10 rs740598 118, 496, 889 S1001393Q 0.0403 0.0107 0.463 0.477 
6 q22 TRDN C_2140539_10 rs1358856 123, 936, 677 S10014070 0.0400 0.0176 0.473 0.486 
18 p11.3 RAB31 C_1371205_10 rs9951171 9, 739, 879 S1001395S 0.0443 0.0196 0.474 0.490 
1 p36 PRDM2 C_340791_10 rs7520386 13, 900, 708 S1001394R 0.0452 0.0180 0.477 0.490 
6 p24-p22.3 HIVEP1 C_9371416_10 rs13218440 12, 167, 940 S1001397U 0.0466 0.0127 0.457 0.479 
6 p24.3 SASH1 C_1256256_1_ rs2272998 148, 803, 149 S1001398V 0.0471 0.0102 0.468 0.490 
2 q31.3 CERKL C_1276208_10 rs12997453 182, 238, 765 S1001396T 0.0475 0.0188 0.445 0.466 
6 q25 SYNE1 C_251223_10 rs214955 152, 789, 820  S10014031 0.0491 0.0172 0.475 0.491 
4 q21.1 RCHY1 C_1880371_10 rs13134862 76, 783, 075 S1OO1400F 0.0537 0.0057 0.456 0.467 
10 q23.3-q24.1 SORBS1 C_7538108_10 rs1410059 97, 162, 585 S1001399W 0.0540 0.0120 0.471 0.482 
5 qter ADAMTS2 C_3153696_10 rs338882 178, 623, 331 S1001401G 0.0563 0.0186 0.467 0.490 
6 q22-q23 THSD2 C_411273_10 rs2503107 127, 505, 069 S1001406N 0.0575 0.0126 0.454 0.463 
5 q35 LCP2 C_3032822_1_ rs315791 169, 668, 498 S1001404J 0.0581 0.0176 0.471 0.485 
11 q23 KBTBD3 C_1636106_10 rs6591147 105, 418, 194 S1001409O 0.0585 0.0191 0.449 0.481 
18 q11.2 B4GALT6 C_7459903_10 rs985492 27, 565, 032 S1001413J 0.0594 0.0149 0.468 0.487 
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Appendix 3. Information for 52 autosomal SNPs used to generate the SNPforID panel.  
NA = Not Available 
*lower case letter defines the base replaced with a pyrimidine derivate P base analogue 
Table adapted from Sanchez, Phillips (39).
Marker Code  Chromosome NCBI human 
chromosome position 
NCBI rs No.  TSC No. PCR Forward Primer (5’ – 3’) PCR Reverse Primer (3’ – 5’) Amplicon Size TSC allele reported  
1 1 4037521 rs1490413 TSC0724193 GTGTGGACTGGGCTGATGT TTCTCACTAGTGTCCCTGCTCTG 68 A/G 
2 2 104974 rs876724 TSC0208870 GCAGGCTCCATTTTTATACCACT GAATATCTATGAGCAGGCAGTTAGC 83 C/T 
3 3 936782 rs1357617 TSC0496080 AGCTGATGCAGACCACTTCAC GGATAGCTGATAAGAAACATGACCA 90 A/T 
4 4 10719942 rs2046361 TSC1065282 CCTATTTGTATGTATCTATTGTCTATGAACG GTCATTGTTGACACTTCACCTTCTA 79 A/T 
5 5 2932133 rs717302 TSC0039610 CTTTAGAAAGGCATATCGTATTAACTGTG AACACAGAAAGAGGTTCATATGTTGG 86 A/G 
6 6 1080939 rs1029047 TSC0253802 CATAACGTGGATTTGTCAGCA GGAATAAACTGAAGGCTAAAGAAAAG 100 A/T 
7 7 4201341 rs917118 TSC0229630 GCCCTTTAGGGTCGGTTC GTAAGAGATGACTGAGGTCAACGAG 87 C/T 
8 8 136017 rs763869 TSC0065968 ATCAAGTGCTTTCTGTTGACATTTG GGCTACTCCCTCATAATGTAATGC 100 C/T 
9 9 1813774 rs1015250 TSC0097236 AAGTGATGGAGTTAGGAAAAGAACC AAGACATTAGGTGGATTCATAGCTG  95 C/G 
10 10 3328178 rs735155 TSC0027519 GGAGAAAACCGGAGAGCTG GAGTGTCACCGAATTCAACG 100 A/G 
11 11 11060530 rs901398 TSC0177752 CTGGGTGCAAACTAGCTGAATATC  CTGGAATGTACTAGGCAAGAAACTAA  70 C/T 
12 12 741262 rs2107612 TSC1108144 GAGCATTCTCTTCTGTTAAAATTGC TGAGTACATTATTCAACTGTTTTGGAG 93 A/G 
13 13 20172700 rs1886510 TSC0904551 GTCCTTGTCAATCTTTCTACCAGAG GGATTTTCACAACAACACTTGC 86 C/T 
14 14 23840960 rs145361 TSC0684657 AGGGAAATACACCCTGAGCTG AGCTGTCCATCATCAGTAAGACAC 73 A/T 
15 15 22119157 rs2016276 TSC0326290 TGCATCCCAGCCTCCACT ATTGTACCTTGCCACTTTGTGTG 90 A/G 
16 16 5606490 rs729172 TSC0028090 CATTAATATGACCAAGGCTCCTCT  ACATTTCCCTCTTGCGGTTAC 60 A/C 
17 17 5907188 rs740910 TSC0105771 GTATAACAGTTTGCTAAGTAAGGTGAGTG AGATAGGTTCGAGTTTTGGCTTTA 87 A/G 
18 18 1117986 rs1493232 TSC0729796 CTATTCTCTCTTTTGGGTGCTAGG CAAACTGTTTATTGTGAGGCCTGT 59 C/A 
19 19 33155177 rs719366 TSC0044247 CCACAGCATCTTTTAACTCTTTTATTATCC GTAAGGACTTATAGTGAGTAAAGGACAGG  105 C/T 
20 20 4442483 rs1031825 TSC0334834 CTTATCTTTCCCACATTATGGTCCT AAGATATAATCACTGCTTTCAAGTATGC 98 A/C 
21 21 15607469 rs722098 TSC0050288 GGAAGTACACATCTGTTGACAGTAATGA  GGGTAAAGAAATATTCAGCACATCC 81 A/G 
22 22 26141338 rs733164 TSC0023085 AGCTTTCAGCCCCAGGTC CGGCTCAGGAATGTCAGG  68 A/G 
23 10 2360631 rs826472 TSC0557086 TGAATTTTGTCTCTGTTATATTAGTCACC TGTAATTGAAATTTGTAGGCAATAGAC 85 C/T 
24 21 28601558 rs2831700 NA GGCTAAACTATTGCCGGAGA TTCCCTAGAACCACAATTATCTGTC 62 G/A 
25 14 96835572 rs873196 TSC0202434 GCATTCAAATCCCAAGTGCT GCAGGAGTTGGAGTCAATCAG 63 C/T 
26 16 79885888 rs1382387 TSC0544547 ACGAAGGAGAAACACCTGAACT TGGAGTACTTAATAAGACGCTGCAT 69 G/T 
27 12 104830721 rs2111980 TSC1113476 AGCATCTTGGCAGCATCC AGCAAGATCTTTGCCAGTGAGT  72 A/G 
28 8 139370172 rs2056277 TSC1082757 CCAAACTGGGTGTTAGGGAGAC TCATTATCTCGTCATACTTCCCTGT  73 C/T 
29 18 73559363 rs1024116 TSC0247167 CCATGTGTTCTAATAAAAAGGATTGC TGGGAAGTGAGCAAAAGTAAATACA  76 A/G 
30 6 164954622 rs727811 TSC0062764 GTGTTTCTTTTTCTCTTACCGGAAC GTGAATGAAATCATGAGATTGCTG 78 A/C 
32 1 239753521 rs1413212 TSC0607362 AACCTCCTTTGGAAACACTGAC  CAACATTCCATTATCCAGGAGAC 84 A/G 
33 17 78065617 rs938283 TSC0357388 CATTGAAGTCCTAACCCCTAGTACG  GGATGAGGCCCACCCATA  85 C/T 
34 4 191013970 rs1979255 TSC0925231 TCAGAGACTATGGATGGTATTTAGGTC CATGGAACGTTGGAACTCTTG  86 C/G 
35 9 122257493 rs1463729 TSC0377760 ACTATCAGTCTCTGCCCTTATTCTG  CACATGTGCATGCTTTTGG 87 A/G 
36 11 134205198 rs2076848 TSC0022275 GCCTCACCACCAGAAATCAG GACATCAGAAACTCCCATGAAACT 89 A/T 
37 3 192127021 rs1355366 TSC0491662 CCATGATTTTCTTGTGGTGAGA CACATGTGCTTAGGCCACAAC 90 A/G 
38 2 239850329 rs907100 TSC0186810 GGAGTTCCTGATAACGATTCTGAAG ACAGAAAAGAAGCcCAGTTGGA*  91 C/G 
39 13 104636412 rs354439 TSC0700528 GGCTTCTCTTTCCCTTATGTATCTC  CAGGTTGCGATAGAAAACAGTGAAT  93 A/T 
40 22 46048653 rs2040411 TSC1056845 TCTGGAATGCCAGTTCTTTTGT CAGAACGCCTATGAAAACCAGT 94 A/G 
41 7 154850085 rs737681 TSC003074 ACATGTGAGGCCATCTCCAC  CCTTACTGTGATGTAGGCACTGTTC 96 C/T 
42 21 27530034 rs2830795 NA CACTTCTATAGACATAGGACACACCAT ATCTAGGCTCTGAATCAGGATGAG 97 A/G 
43 5 174759601 rs251934 TSC0220872 AGAGGGCAGTGAGGCTTTTAAGTAG  TGCTAGAATCCAGACTTAACTACCAG 98 C/T 
44 21 41336325 rs914165 TSC0197658 AGCAGCAGAGCCTGGATG AGACCAGTCACCTCTTTTGCACT 100 A/G 
45 1 235480457 rs10495407 NA AGATCTCCACTTCCTCTTGGTTG CTCCCAAATTTACATTGCCACT  102 G/A 
46 9 1234344108 rs1360288 TSC0501229 AGACTCTCTGTGTGTGGCTTTG GAGGGGGCATCTGTTGAG  103 C/T 
48 10 132172819 rs964681 TSC0270699 GTACCTGGAGGTGATTTCTGTGAG GTTATGGAGGATTGGTAAGAACCAG 106 C/T 
49 20 40172539 rs1005533 TSC00802071 GGTTTGTGTGTGAGTGTTTCAGAT  CCTTATGCCTCCCCTGAAC 107 A/G 
50 15 51332965 rs8037429 NA TTCACTTTGCTACACCTCCATAGTA TGCTACGTAAGAGGTCATTGCTATC 108 C/T 
51 1 236923075 rs891700 TSC0162577 TTTTCAGAGGTGGTATTTCTAGCTG GCTATGACACTCCTTAGAACTATGCAA  109 A/G 
52 13 18699724 rs1335873 TSC0829150 GTGGATGATATGGTTTCTCAAGG TTCAACAAACGTGTGATGCTCT  110 A/T 
53 22 46574531 rs1028528 TSC0253071 ACAGCTGATGCCTCCCTGA GAGGATGAAGGTTAGAGCCAGAC 113 A/G 
54 15 52926761 rs1528460 TSC0798410 TCCTGGAGATCAATATTTAGCCTTA GGGTGACCAGTAGTTCTATGAGC 115 C/T 
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Abstract  
 DNA sequencing is a valuable tool within forensics. Traditionally DNA sequencing is 
conducted in a centralised laboratory that requires the use of specialised equipment and highly 
trained individuals to interpret the results, which is known to be costly and time consuming. 
The demand for DNA sequencing within forensic is increasing, prompting demand for 
improved sequencing technologies. Oxford Nanopore Technologies released the MinIONÔ 
sequencer, a portable sequencing platform that is able to discriminate single molecules in real 
time. The research presented here aimed to develop a targeted PCR amplification approach 
for STRs, SNPs and mtDNA before sequencing with MinIONÔ to allow for rapid identification 
of an individual in an in-field environment. The use of a targeted approach to isolate regions 
of forensic interest was demonstrated; however, the method presented here has not 
superseded current forensic DNA typing methods. It does however demonstrate the potential 
of in-field sequencing platforms for use in forensic applications. 
Keywords 
 DNA Sequencing, MinION, Rapid, In-field, Forensics. 
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1. Introduction 
Since the development of Sanger Sequencing by Fredrick Sanger in 1975, the discipline 
of genomics has undergone vast development (1). Also referred to as first-generation 
sequencing, these initial sequencing platforms aided many developments within biological 
science (1). However, these methods are limited by low throughput and high costs. 
Advancements in polymerase chain reaction (PCR) and recombinant DNA technologies as well 
as the demand for more affordable, faster sequencing technologies led to the introduction of 
second-generation platforms (1). Also referred to as next-generation sequencing (NGS) these 
platforms include the Roche 454 pyrosequencing, Illumina/Solexa, ABI SOLiDÒ, and Thermo 
Fisher Ion TorrentÔ (2). These systems, particularly the Illumina platform, have had a 
dominant position in the genomics market as they can provide faster and cheaper results than 
their first-generation counterparts (1-3). However, they are limited by short read lengths and 
fragmented genome assemblies, prompting the development of third-generation sequencing 
technologies (1).  
Third generation platforms offer increased read length, a reduction in sequencing time 
and the biases introduced by PCR amplification (1). The most notable third-generation 
technology is nanopore sequencing (2). Nanopores allow for a single-molecule sequencing 
approach (4). Biological nanopores are a protein channel that is formed in a lipid bilayer while 
solid-state nanopores are synthetically manufactured by drilling or etching into a solid-state 
substrate (4). The a-Hemolysin (a-HL) exotoxin secreted by Staphylococcus aureus is the most 
commonly used biological nanopore and has been exploited by Oxford Nanopore Technologies 
(ONT) to develop the Oxford Nanopore MinIONÔ sequencer (5).  
MinIONÔ is a third-generation portable sequencer that utilises nanopores to detect 
and discriminate single molecules in real time (3, 6). At approximately 10 x 3.2 x 2 cm in size 
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and 90 g in weight, the MinIONÔ is a portable device powered by a USB 3.0 connection to a 
laptop computer (7). It is advantageous due to low cost, speed and portability and ability to 
create long reads (7). As such, it is proposed for use in portable sequencing applications, with 
the platform having already been utilised for bacterial species identification on the 
International Space Station, as well as during diagnostic testing throughout the Ebola and Zika 
virus outbreaks (7-12). Despite the appeal, research has highlighted that the MinIONÔ is 
limited by high error rates, inaccurate reads and issues with data analysis (6, 13, 14).  
Within forensics the analysis of DNA is a powerful investigative tool; however, forensic 
DNA samples are often highly degraded and contaminated; therefore, an accurate and 
effective analysis that is time and cost efficient is essential (3). Currently, forensic DNA typing 
is performed by the analysis of highly polymorphic short tandem repeat (STR) loci (15). This 
involves the extraction of DNA from a forensic sample, quantification, PCR based amplification 
of STR regions followed by separation and detection of PCR products by capillary 
electrophoresis (CE) (16). This process occurs in a centralised laboratory environment with 
specialised equipment and highly trained individuals to interpret the results and can take 24 – 
72 hours for a buccal swab to be processed; therefore, this process is considered costly and 
time-consuming (17). The increased demand and recovery of DNA from forensic investigations 
has led to processing backlogs at these laboratory facilities, which are said to be limiting the 
potential of forensic DNA analysis (18, 19).  
Consequently, with the advancement of biological science and sequencing 
technologies that idea that DNA analysis needs to occur at a centrally based laboratory is being 
challenged, with in-field sequencing proposed as an alternative (20). A range of in-field 
systems, such as RapidHITÔ (Integen), DNAScan/ANDEÔ and ParaDNA (LGC) have been 
described (17, 21-27). While all of these platforms have shown concordance with traditional 
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methods the major disadvantage of these platforms is the ability to be fully portable within the 
field; leading to the demand for new sequencing approaches, subsequently, the literature has 
investigated the potential for MinIONÔ sequencer to be used in forensic applications (1).  
Research conducted by Michaels (28) utilised MinIONÔ to determine if messenger RNA 
(mRNA) sequence analysis could be used for the rapid identification of semen, saliva, blood, 
vaginal fluid, and menstrual blood (28). The study targeted two genes for each fluid type and 
was able to identify each fluid successfully. However, the authors identified issues with flow 
cell contamination from previous library preparations and gene degradation, while highlighting 
limitations with amplicon length and input requirements for the MinIONÔ system (28). 
Cornelis, Gansemans (29) investigated if MinIONÔ could be used for forensic genotyping of 
single nucleotide polymorphisms (SNP). Of the 52 investigated SNPs, 51 were correctly typed 
used MinIONÔ sequence analysis; however, issues with low mapping and sequencing errors 
with homopolymer sequences were identified. Cornelis, and Gansemans (30) then investigated 
the analysis of tri-allelic SNPs, which have a higher discriminatory power than bi-allelic SNPS, 
while the authors identified that this methodology could achieve greater coverage, they also 
highlighted the need for analysis pipelines to create a better balance between coverage and 
the quality of reads. Sim and Chapman (31), utilised MinIONÔ to conduct whole genome 
sequencing in an in-field forensic setting. While the study did not identify any STR regions, 
which was attributed to low read accuracy and depth of coverage the authors suggested that 
future research should use PCR amplification before sequencing for a targeted approach (31). 
The work presented here will follow on from the research conducted by Sim and 
Chapman (31). Before MinIONÔ sequencing, a targeted PCR amplification approach will be 
utilised. While STR typing is the current standard for forensic DNA typing, it has been 
demonstrated that STR typing may not always be appropriate for forensic samples, which are 
 51 
often degraded or of low quality (32). Therefore, this study will also target SNPs and 
mitochondrial DNA (mtDNA), as these have been suggested as alternative targets for forensic 
DNA typing (32-37). Therefore, this research will aim to develop a PCR protocol that will amplify 
five STR, five SNPs and the mitochondrial D-loop in a single assay for increased discrimination 
for human identification.  
2. Materials and Methods  
2.1. Target Selection  
 Five STRs and five SNPs were selected for inclusion in this study. The selection criteria 
for the STRs were that they were; 1) included in the US and EU core expanded STR loci sets, 2) 
unlinked genetically, 3) ranked highly for human discrimination and, 4) inclusion of Amelogenin 
for sex determination. The selection criteria for the SNPs were 1) known to be specific for 
human identification, 2) low Fst value, 3) high heterozygosity and, 4) unlinked genetically. The 
mitochondrial d-loop region was also investigated to allow for identification if no nuclear DNA 
(nuDNA) is obtained from the STR and SNP analysis.  
2.2. Research Strategy 
Figure 1 shows a diagrammatic representation of the research strategy to be utilised in 
this study. Due to the input requirements of the MinIONÔ device a fragment of control DNA, 
needs to be ligated to the PCR amplified samples. The ligated samples will then go on to library 
preparation and MinIONÔ sequencing. 
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Figure 1. Diagrammatic representation of the scientific strategy for this research.  
2.3. Primer Design  
 Primers included for use in this study were selected from primers previously published 
in the literature (38-42). The primers were tested for primer – primer activity using the Thermo 
Scientific Multiple Primer Analyser. As the primers had been previously designed the selected 
primer sequences were checked against the Homo sapiens genome GRCh38.p12 accession 
number GCA000001405.27 (NCBI), to ensure that they would anneal and incorporate the 
target region. Primer analysis was conducted with the OligoAnalyzer Tool (IDT). Primers were 
sourced from IDT. Primers were resuspended to 100 µM in nuclease-free water and then 
diluted 1:10 to make a 10 µM working solution.  
Target Selection 
Sample Collection
DNA Extraction
PCR Amplification of Targets
PCR Clean Up
DNA Quantification
End Repair 
Fragmentation of 2800M DNA 
Fragment Size Analysis 
Quantification of 2800M DNA
Ligation of PCR Amplified 
Samples to 2800M
Library Preparation
Sequencing with MinION™
Data Analysis
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2.4. Sample Collection 
Two samples were collected; a forensic sample and a reference buccal sample. The 
samples were collected with Rayon Sterile Swabs (Copan). The forensic sample was collected 
by swabbing a region of a KeepCupÓ tempered glass cup known to have been used by the 
volunteer. The reference sample was taken by performing a buccal swab from the volunteer 
as previously described by Walker, Najarian (43). Samples were stored at 4°C until required.  
2.5. DNA Extraction  
 DNA extraction was performed with the QIAamp DNA Investigator Kit (Qiagen) using 
the Isolation of Total DNA from Surface and Buccal Swabs protocol as per the manufacturer’s 
guidelines. DNA was eluted in 40µl of Buffer ATE.  
2.6. PCR Amplification  
PCR was performed using the Taq Ti-1 Hot Start DNA Polymerase (Fisher Biotech) as 
per the manufacturer’s guidelines for a 25 µl reaction volume. Samples were cycled using the 
ProFlex PCR System (Applied Biosystems) with the following conditions. Initial denaturation at 
94°C for 3 minutes, 30 cycles of 94°C for 30 seconds, 55°C for 30 seconds, 75°C for 45 seconds, 
with final extension at 75°C for 5 minutes and a final hold at 4°C. PCR products were analysed 
by electrophoresis on a 2% agarose gel (Fisher Biotech), with the Gene Ruler 100bp Plus DNA 
allelic ladder. The gel was run at 80V and visualised using a UV transilluminator. 
2.7. PCR Clean Up  
PCR products for each sample type (forensic sample and reference buccal) were pooled 
together and cleaned up using the QIAquick PCR Purification Kit (Qiagen) as per the 
manufacturer’s guidelines.  
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2.8. Fragmentation of 2800M Genomic Control DNA  
2800M genomic control DNA (Promega) was fragmented using the Covaris M220 
Focused Ultrasonicator. The protocol used 50 µl of 2800M DNA in a 50 µl screw cap. 
Fragmentation occurred under the following settings; peak incident of 50 watts, duty factor 
20%, and 200 cycles per burst. Fragmentation time intervals were set at 10, 12, 15, 25, 50, 100, 
200, and 400 seconds. Fragmented samples were analysed on the Agilent 2100 Bioanalyser 
using the High Sensitivity DNA assay as per the manufacturer’s guidelines.  
2.9. DNA Quantification  
Purified PCR products and fragmented 2800M DNA were quantified on the Qubit 3.0 
Fluorometer using the dsDNA HS assay (Invitrogen). 10 µl of the sample was added to each 
tube and made up to 200 µl with the working solution.  
2.10.  End Repair  
End Repair was performed using the NEBNextÒ End Repair Module (NEB) as per 
manufacturer’s guidelines. Samples were purified using the QIAquick PCR Purification Kit 
(Qiagen) as per the manufacturer’s guidelines. 
2.11. Ligation to 2800M Control DNA 
To overcome the input requirements of MinIONÔ, a control fragment of DNA was 
ligated to the PCR amplicons. Two ligation reactions were set up; reference buccal with 2800M 
and forensic sample with 2800M. Ligation was performed using the Blunt/TA Ligase Master 
Mix (NEB) as per the manufacturer’s guidelines. The reference buccal sample was diluted 1:100 
in nuclease free water to obtain a concentration suitable for ligation input requirements.  
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2.12. Library Preparation  
The lambda control library was prepared as per manufacturer’s guidelines for the 1D 
Lambda Control Experiment (ONT). Library preparation for the reference buccal and forensic 
sample was conducted per the manufacturer’s guidelines for the 1D Genomic DNA by Ligation 
(ONT) protocol. For both library preparations, the DNA repair and end-prep steps were 
omitted. Adapter ligation for both protocols was performed per guidelines with Blunt/TA 
Ligase Master Mix (NEB). For the 1D genomic DNA by ligation protocol, the only deviation was 
that 10 µl of DNA was made up to a volume of 60 µl with water, as insufficient DNA volumes 
were present following ligation with 2800M control DNA. All library preparations were 
quantified using Qubit 3.0 Fluorometer and the dsDNA HS assay (Invitrogen). 
2.13. Nanopore Sequencing with MinIONÔ 
ONT recommends that 12 µl of DNA library at 5 -50 fmol be added to the sequencing 
reaction. For the lambda control, 5 µl of the undiluted library at 1.49 ng/µl was added to the 
sequencing reaction (as instructed by ONT technical support). For the forensic and reference 
buccal sample 6 µl of the library at 0.112 ng/µl and 0.192 ng/µl respectively was diluted with 
6 µl of elution buffer (as instructed by ONT technical support). Sequencing for the lambda 
control, reference buccal and forensic sample libraries were conducted on the MinIONÔ MIN-
101B sequencer with the R9 flow cell FLO-MINSP6 with the parameters set as outlined in the 
1D Genomic DNA by Ligation protocol (ONT). The reference sample was sequenced on the 
same flow cell as the lambda control, with the recommended wash protocol used between 
sequencing protocols. The starting voltage for the reference sequencing run was adjusted to -
185 mV as recommended by the manufacturer to account for voltage drift from the previous 
run. The sequencing data was acquired using the MinKNOW software (ONT).  
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2.14. Data Analysis  
The EPI2MEÔ program (ONT) was used to conduct species identification for the 
reference buccal and forensic sample with the What’s in My Pot (WIMP) workflow. The FASTQ 
sequence files generated from MinKNOW were uploaded to GeneiousÒ Prime (Biomatters) 
version 2019.2.1. The primer sequences were uploaded and mapped to the sequencing reads 
using the test with saved primers function. PCR products were extracted using the extract PCR 
products function. The generated PCR products were manually interrogated to determine 
genuine PCR products. PCR products were aligned to their respective reference sequence, 
obtained from the Homo sapiens genome GRCh38.p12 accession number GCA000001405.27 
(NCBI), alignment was conducted using the Map to Reference function, with medium 
sensitivity. When only one read was isolated per amplicon the read was aligned to the 
reference using pairwise alignment. The alignments were manually interrogated to determine 
the allele repeat and compared to the allele repeats described by the STR database; STRBase 
(NIST) (44). Amelogenin sequencing reads were blasted using blastnÒ to determine their 
identity (45). To evaluate concordance, the observed STRs were compared to a known STR 
profile generated using traditional STR analysis with GlobalFiler. The SNP reads were blasted 
using blastnÒ to determine the polymorphism and compared to the variant information 
obtained from the dsSNP database (NCBI) (45, 46). mtDNA reads were aligned to the revised 
Cambridge Reference Sequence (rCRS) (NCBI), the alignment was manually investigated for 
base changes at positions previously described by Weiler, de Vries (47) and Chemale, Paneto 
(48) and compared to polymorphisms reported on the MITOMAP database (49). 
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3. Results and Discussion  
3.1. Target Selection  
The STRs chosen for inclusion in this study were D1S1656, D12S391, D18S51, FGA and 
Amelogenin. The selected SNPs were rs1357617, rs1029047, rs763869, rs735155 and 
rs729172. The mitochondrial D-loop hypervariable region 1 (HVR1) and 2 (HVR2) were also 
selected. 
3.2. Primer Design  
 The primers used in this study were previously described in the literature (38-42); the 
selected primer sequences are shown in Table 1. The primer properties obtained using the 
OligoAnalyzer Tool (IDT) are shown in the Appendix. A previously published primer sequence 
could not be found for the mitochondrial HVR1; for this reason, HVR1 was omitted from the 
study. As the primer sequences had been previously designed the sequences were aligned 
against the Homo sapiens genome GRCh38.p12 accession number GCA000001405.27 (NCBI), 
this identified a mismatch in the FGA reverse primer sequence as defined by Seidenberg, Schilz 
(40). The first two base pairs AT in the 5’ to 3’ direction were a mismatch and were changed to 
GC so that full alignment could be achieved.  
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Table 1. Primer Sequences for the selected SNPs, STR and Mitochondrial regions 
A: adenine C: cytosine G: guanine T: thymine 
*Bases shown in bold were changed from the previously published sequence as a mismatch was identified when the sequence was compared 
against the Homo sapiens genome GRCh38.p12. 
STRs 
Loci Chromosome Forward Primer 5’ – 3’  Reverse Primer 5’ – 3’  Amplicon Size (bp)  Reference  
D1S1656 1 GTGTTGCTCAAGGGTCAACT GAGAAATAGAATCACTAGGGAACC 121 - 169 (41) 
D12S391 12 ACAGGATCAATGGATGCATAGG CAGCCTCCATATCACTTGAGC 129 - 173 (41) 
D18S51 18 TGAGTGACAAATTGAGACCTT GTCTTACAATAACAGTTGCTACTATT 109 - 189 (38) 
FGA 4 AATAAAATTAGGCATATTTACAAGCTAG *GCTGCTGAGTGATTTGTCTGTAATTG 149 - 181 (40) 
Amelogenin - CCCTGGGCTCTGTAAAGAATAGTG ATCAGAGCTTAAACTGGGAAGCTG 104 -110  (38) 
SNPs 
NCBI rs Number Chromosome Forward Primer 5’ – 3’  Reverse Primer 5’ – 3’  Amplicon Size (bp) Reference  
rs1357617 3 AGCTGATGCAGACCACTTCAC GGATAGCTGATAAGAAACATGACCA 90 (42) 
rs1029047 6 CATAACGTGGATTTGTCAGCA GGAATAAACTGAAGGCTAAAGAAAAG 100 (42) 
rs763869 8 ATCAAGTGCTTTCTGTTGACATTTG  GGCTACTCCCTCATAATGTAATGC 100 (42) 
rs735155 10 GGAGAAAACCGGAGAGCTG GAGTGTCACCGAATTCAACG 100 (42) 
rs729172 16 CATTAATATGACCAAGGCTCCTCT ACATTTCCCTCTTGCGGTTAC 60 (42) 
Mitochondrial D-loop 
Region Chromosome  Forward Primer 5’ – 3’ Reverse Primer 5’ – 3’ Amplicon Size (bp) Reference 
HVR2 - GGTCTATCACCCTATTAACCAC GCTTTGAGGAGGTAAGCTAC 594  (39) 
 59 
3.3. Species Determination of Sequenced DNA  
The WIMP analysis pipeline on EPI2MEÔ (ONT) characterises passed sequence reads 
into taxonomies specific to the genus level (50). The WIMP results for the reference buccal and 
forensic sample are shown in Table 2. The forensic sample generated 2455 total reads, of which 
1763 were classified, these reads had an average length of 1446 base pairs (bp), with the 
longest read 16573 bp. Of the classified reads 1694 were mapped to the Homo genus. The 
reference buccal generated 646 total reads, of which 448 were classified. The average read 
length was 1577 bp with the longest read 21688 bp. Of the 448 classified reads 376, were 
mapped to Homo genus.  
For the forensic sample, 99% of the sample was characterised as eukaryotic and 1% 
bacterial, while the reference buccal was characterised as 91% eukaryotic, 9% bacterial and 
<1% viral (Figure 1). When compared to the WIMP results obtained by Sim and Chapman (31), 
where no PCR amplification was used before sequencing with MinIONÔ, the forensic sample 
was characterised as 74% bacterial, 16% eukaryotic and 11% viral and the reference sample 
characterised as 98% eukaryotic and 2% bacterial. Therefore, the results obtained in this study 
demonstrate that the use of PCR step to target the regions of interest before sequencing is 
beneficial for forensic identification when using MinIONÔ sequencing, as it reduces the 
isolation of bacterial and viral genomes. 
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Table 2. Total reads for the reference buccal and the forensic sample and characterisation of 
top four genus by number of reads by WIMP analysis. 
Reference Buccal Forensic Sample 
Total 
Reads 
Classified 
Reads 
Unclassified 
Reads 
Total 
Reads 
Classified 
Reads 
Unclassified 
Reads 
646 448 199 2455 1763 692 
 
Genus Reads Genus Reads 
Homo 376 Homo  1694 
Escherichia 29 Cutibacterium 19 
Streptococcus 4 Colletotrichum 3 
Thermothelomyes 3 Marssonia 3 
 
 
(a) (b) 
Figure 2. Percentage characterisation of (a) forensic sample and (b) reference buccal from 
WIMP analysis. 
3.4. Isolation of Targets from Sequencing Data 
Following extraction of the PCR products in GeneiousÒ, all products were manually 
investigated. Products with mismatching primer pairs and products that were longer than the 
expected amplicon size were omitted. This was attributed to the failure for complete removal 
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of primers following PCR clean up and subsequent ligation of these primers to the 2800M 
sequence. Furthermore, the 2800M DNA was not barcoded during library preparation and 
therefore, could not be identified post-sequencing, which impacted the ability to extract 
genuine PCR products bioinformatically. Despite this, all targets were identified in the forensic 
sample, while only two STRs (D12S391 and D1S1656), one SNP (rs1357617) and the mtDNA 
HVR2 were isolated in the reference buccal.  
This result was unexpected, as the assumption is that all targets would be seen in the 
reference buccal and the forensic sample would have limited isolation of targets. In this study, 
the forensic sample was sequenced on a new flow cell, while the reference buccal was 
sequenced on the same flow cell as the lambda control experiment. It could be proposed that 
by reusing the flow cell, the sequencing output of the reference buccal was affected. Flow cells 
can be reused; however, this is subject to the integrity of the flow cell (6). A flow cell check was 
performed before sequencing the reference buccal, with 1249 active pores available, which is 
above the minimum 800 suggested by ONT, so it is unlikely that the lack of target isolation in 
the reference buccal was the result of a faulty flow cell. The starting voltage for the flow cell 
was adjusted for sequencing of the reference buccal as suggested by ONT to allow for voltage 
drift from the previous sequencing run. It is therefore probable that the flow cell needed to be 
refuelled with additional library preparation during the sequencing run to allow the quality of 
the sequencing reaction to return to levels seen at the start of the run (14).  
3.5. Analysis of STRs and Determination of Genotype 
The use of nanopore sequencing for forensic genotyping is a novel technique with 
limited research available. The GeneiousÒ assembly tools have not been tested on MinIONÔ 
sequencing due to the high error rates; therefore, de novo assembly of reads will likely be 
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unsuccessful. It is recommended that reads are mapped to a reference genome. Reads were 
mapped to the respective reference sequence obtained from the Homo sapiens genome 
GRCh38.p12 accession number GCA000001405.27 (NCBI). The alignment was then manually 
interrogated to determine the STR repeat and compared to the allele repeats published on 
STRBase (NIST). 
Table 3 shows the characterised alleles for each read from the forensic sample and 
reference buccal. All five STR targets were isolated in the forensic sample. Eighteen reads for 
D12S391 were mapped to the reference sequence; of these five reads were able to be 
characterised with an allele repeat; they were 20, 15, 17, 17 and 15. Eight reads for D1S1656 
were mapped to the reference sequence; of these two were reads were characterised as 
repeat number 17.3. For D18S51 only one read was isolated and was therefore pairwise 
aligned to the reference sequence, this alignment had a pairwise identity of 58.3%. Due to poor 
alignment it was difficult to characterise, and no allele repeat could be allocated (51). Two 
reads were mapped for FGA; these reads were characterised as 20.2 and 20 respectively. 
Unlike the other STRs investigated Amelogenin does not have a genotype; therefore, the 
mapped reads for Amelogenin were blasted to determine their identity, of the 14 isolated 
reads nine aligned to the AMELX gene, while five aligned to the AMELY gene (not shown). 
For the reference buccal sample, only two STRs; D12S391 and D1S1656 were isolated. 
Four reads for D12S391 were mapped to the reference genome; only one could be 
characterised with an allele repeat of 15. For D1S1656 one read was pairwise aligned to the 
reference and was characterised with an allele repeat of 14. 
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3.6. Comparison of MinIONÔ Generated STR Profile to Known Profile  
To evaluate concordance, the STR results obtained from MinIONÔ sequencing was 
compared with a known STR profile of the volunteer generated using traditional sequencing 
with GlobalFiler (Table 3). At D12S391 the volunteer has a genotype of 17, 21. The results 
obtained show that MinIONÔ sequencing was able to identify the 17 allele but was unable to 
characterise the 21 allele accurately. At D1S1656 the known genotype is 15, 17.3. The 17.3 
allele was accurately characterised in the forensic sample. For FGA the known genotype is 20, 
22, the 20 allele was successfully characterised using MinIONÔ sequencing. In the reference 
buccal sample, the observed alleles did not show concordance with the known profile. For 
Amelogenin, the known profile identifies an individual with an X, Y profile; this was also 
represented in the forensic sample but not the reference buccal. These results show that the 
targeted approach to MinION sequencing demonstrated an element of concordance with 
traditional methods; however, this method was unable to generate a complete genotype for 
human identification in a forensic context. Therefore, the application of MinIONÔ in forensic 
science must be considered. Currently, the device cannot be used for forensic identification of 
an individual, instead the device should be considered for use as a presumptive identification 
method, which will be useful in remote and isolated environments where a presumptive result 
may progress the forensic investigation until traditional analysis can be conducted. 
The error rate of MinIONÔ is identified as one of the most significant issues preventing 
the inclusion of this technology in forensic science (6). Insertions and deletions are identified 
as the most common type of error encountered during MinIONÔ sequencing (37). If the 
MinIONÔ sequencing data generated for the STRs in this study is reanalysed assuming the 
base identity of the errors, then it could be proposed that the first read for FGA in the forensic 
sample could be classified as a 22 allele instead of a 20.2; therefore, matching the known 
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profile, and generating complete concordance with the known profile. Similarly, in the first 
read of D12S391 in the forensic sample if you assume the identity of the deletions and account 
for sequencing error the read could be classified as 17 allele. However, these are only 
assumptions, and forensic identification cannot be based on assumptions. Therefore, the 
results generated here do not supersede those of current identification processes. Forensic 
identification processes require accurate identification methods, if MinIONÔ sequencing is to 
be used for forensic purposes the error rates and data analysis protocols need to be improved. 
For human identification depth of coverage is required, while MinIONÔ creates long read 
length it is not supported by depth of coverage, which affects the ability to make an accurate 
identification (51). ONT is known to be continually developing their flow cell technology and 
sequencing chemistry; therefore, it is expected that with time these issues will be resolved and 
the use of MinIONÔ for forensic identification will become more feasible (6).  
3.7. Analysis of SNPs 
All targeted SNPs were isolated in the forensic sample; the SNPs were mapped to their 
respective reference sequence and then blasted using blastnÒ to determine the presence of 
polymorphism (Table 4). The reported polymorphism for rs763869 is A>G change at position 
1427444, of the eight reads mapped for this SNP four of these reads, had A>G polymorphism. 
Three reads were mapped for rs735155, at position 3331986 one of the reads had a 
polymorphism from a G>A; however, the reported polymorphisms at this position are C>T or 
C>G. It could be speculated that this is a new polymorphism; however, there is no comparison 
available to verify this; therefore, due to a lack of coverage and the known error rate of 
MinIONÔ, it is more likely that this is a sequencing error.  
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For rs729172 the reported polymorphism is G>A or G>C or G>T change at position 
5556196, of the four isolated reads for this SNP no polymorphism was identified. Of the five 
reads isolated for rs1357617, one had A>T polymorphism at position 920099, which is the 
expected polymorphism at this site. For rs1029047 six reads were mapped to the reference 
genome, but when these were blasted, no similarity was found. In the reference buccal sample, 
only rs1357617 was isolated; however, no polymorphism identified. There is no known profile 
to compare these results to; therefore, the results seen here cannot be verified. Despite this, 
the results have shown that SNPs specific for human identification can be identified using a 
targeted MinIONÔ sequencing method. 
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Table 3. STR Genotypes. Characterised alleles for the forensic sample and reference buccal. The known profile was obtained from a commercial 
STR kit (GlobalFiler).  
-  No allele characterised for this read. 
N/A No respective read.  
  
  
 
Forensic Sample  Reference Buccal 
STR 
 
Known 
Profile 
Read 
 
Read 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 1 2 3 4 
D12S391 17, 21 - 20 15 - - 17 - 17 - - 15 - - - - - - - - - 15 - 
D1S1656 15, 17.3 - 17.3 17.3 - - - - - N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 14 N/A N/A N/A 
D18S51 13,17 - N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
FGA 20,22 20.2 20 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Amelogenin X, Y Y Y Y X Y X X X Y X X X X X N/A N/A N/A N/A N/A N/A N/A N/A 
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Table 4. SNP Polymorphisms identified in the forensic sample and the reference buccal. Expected polymorphisms and nucleotide positions 
obtained from dsSNP database. 
 
A: adenine C: cytosine G: guanine T: thymine 
-  No polymorphism identified for this read. 
N/A No respective read 
NS No similarity found on blastn 
    
 
Forensic Sample  Reference Buccal 
SNP 
 
Expected 
Polymorphism 
Nucleotide Position 
Read Read 
1 2 3 4 5 6 7 8 1 2 3 4 
rs763869 G>A 1427444 G>A G>A G>A - - G>A - - 
N/A N/A N/A N/A 
rs735155 C>G/ C>T 3331986 - G>A - N/A N/A N/A N/A N/A - N/A N/A N/A 
rs1357617 A>T 920099 - A>T - - - N/A N/A N/A N/A N/A N/A N/A 
rs729172 G>A/G>C/G>T 5556196 - - - - N/A N/A N/A N/A N/A N/A N/A N/A 
rs1029047 T>A/T>G 1135704 NS NS NS NS NS NS NS NS N/A N/A N/A N/A 
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3.8. Analysis of mtDNA 
The mitochondrial haplotype is recorded as differences in the universal sequence as 
defined by Anderson, Bankier (52). A range of mtDNA SNP panels specific for forensic 
identification has been described (47, 48). SNPs in the HVR2 are located at position 73, 146, 
150, 152, 182, 185, 195, 489 and 497. The polymorphisms identified at these positions in the 
forensic sample and the reference buccal are shown in Table 5. Within the HVR2 one of the 
most common polymorphism is 73G, this was demonstrated in both sample types with the 
A>G polymorphism seen 49 times over 54 reads in the forensic sample and five times over six 
reads in the reference buccal (53). At position 150 in both samples, the C>T polymorphism was 
seen in all reads. At position 152 the T>C polymorphism occurred 52 times; however, this was 
not reflected in the reference buccal. At position 182 and 497, a C>G polymorphism was 
identified; this change was not reported on MITOMAP, therefore, as these polymorphisms are 
not represented in the reference buccal and due to the known error rate of MinIONÔ this is 
most likely that this is a sequencing error. No known mtDNA profile was available for the 
volunteer; therefore, these results could not be verified. A haplotype can then be determined 
from the mtDNA SNPs; however, this was beyond the scope of this study and was not 
investigated but should be investigated in future studies. 
The mtDNA isolated from the forensic sample had the most coverage of any target, 
with 54 times coverage, this was expected as mtDNA has a high resistance to degradation and 
a high copy number compared to nuDNA (54). The analysis of mtDNA in forensics is useful as 
forensic samples are often degraded, therefore the analysis of STR and SNPs may fail. 
Traditionally, mtDNA analysis is considered time consuming, expensive and a complex task 
(48). Therefore, the development of a screening method using MinIONÔ sequencing system 
 69 
could prove beneficial for forensic casework (48). It has been proposed that 32 mtDNA SNPs 
are required to allow for individualisation of biological material; thus, future studies should 
expand on the mtDNA SNPs investigated to increase the discrimination power of the 
identification (55).  
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Table 5. mtDNA SNP Polymorphisms identified in the forensic sample and reference buccal. 
Polymorphisms obtained from MITOMAP database. 
Nucleotide Position 
 
Polymorphism 
 Forensic Sample  Reference Buccal 
54 reads 6 reads 
73 
A>G 49 5 
A>T 1 - 
A>C - 1 
A>del 3 - 
146 
 T>C  1 
 
- 
T>del 1 - 
150 
 
C>T 
 
54  6 
152 
 T>C  52 
 
- 
T>del 2 - 
182 
 C>T 
 
2 
 
- 
C>G* 2 - 
185 
 G>A  3 
 
- 
G>del 2 - 
189 
 A>T  2 
 
- 
A>del 1 - 
195 
 T>C  4 
 
1 
T>A 1 - 
T>del 3 - 
489 
 T>C  2 
 
- 
T>del 3 - 
497 
 C>T  2 
 
2 
C>G* 1 - 
C>del 1 - 
A: adenine C: cytosine G: guanine T: thymine 
- polymorphism not identified 
* polymorphism not reported on MITOMAP database 
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3.9. Limitations  
Due to the input requirements of the MinIONÔ sequencer, a ligation protocol was 
added to ensure the amplicons would meet the minimum length requirement (29). The 2800M 
control DNA (Promega) was selected for use in this study, while the genotype is known, the 
sequence is not. This caused issues, when analysing the data, it was evident that the 2800M 
DNA could not be bioinformatically isolated, as it wasn’t barcoded either this added to 
bioinformatic processes as the generated PCR products had to be manually investigated to 
identify genuine PCR products. Forensic investigations require accurate identification with 
minimal manipulation; therefore, the addition of a secondary DNA sequence, such as 2800M, 
is not ideal as the final identification may be subject to speculation. Furthermore, the 
methodology utilised in this study utilised the ligation sequencing flow cell and related 
protocol, this was labour intensive involving multiple steps and reagents, within a remote in-
field setting this is not ideal, as the environment may not be able to support the methodology. 
ONT is constantly updating their flow cells and with development of the MinIONÔ system it is 
expected that the platform will be able to sequence short amplicons and a ligation protocol 
will no longer be required which will be more suitable for forensic applications (6).  
The MinIONÔ system has known issues with sequencing error and data analysis which 
were demonstrated in this study (6, 13, 14). Sequencing error meant that some reads were 
unable to be characterised or were characterised incorrectly. Additionally, while GeneiousÒ 
supports MinIONÔ sequencing files the platform does not yet support analysis of the data; 
therefore, the analysis utilised here is not representative of how sequencing data would be 
traditionally analysed in forensic applications. With continued development and research of 
MinIONÔ it is expected that the sequencing error will be reduced, and data analysis programs 
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will be developed that are able to accommodate the data and perform analysis specific for 
human identification in forensic applications. 
4. Conclusion  
This study demonstrates proof-of-concept for the targeted amplification of STRs, SNPs 
and mtDNA prior to sequencing with MinIONÔ. The targeted approach reduced the isolation 
of bacterial and viral genomes. The study also demonstrated the ability to characterise STR 
alleles, identity informative SNPs and mtDNA SNPs, from MinIONÔ generated sequencing 
data. However, the STR results demonstrated limited concordance to traditional STR 
sequencing methods. The method described here does not provide enough discrimination or 
accuracy to supersede current processes. Furthermore, complete isolation of the selected 
targets was not achieved in the reference buccal; therefore, the reuse of flow cells in a forensic 
context needs to be considered. Future studies should look to analyse samples concurrently 
with traditional sequencing methods, to allow for a comparison between methods and an 
evaluation of the error rate of MinIONÔ. There is potential for MinIONÔ to be used in-field 
for forensic identification; however, more research and development is required. Continued 
research in this field will be beneficial as the development of an in-field sequencing protocol 
will be beneficial for environments that cannot support fully equipped laboratories. It will also 
see a reduction in time between sample collection and analysis allowing for quicker 
identification and thus reducing backlogs that are currently experienced by traditional 
methods.  
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6. Appendix 
Appendix 1. Primer Properties 
Name Sequence Complement Length GcContent MeltTemp MolecularWeight ExtinctionCoefficient nmole/OD260 µg/OD260 ΔG Tm 
Amelogenin F CCC TGG GCT CTG TAA AGA ATA GTG  CAC TAT TCT TTA CAG AGC CCA GGG  24 50 57 7392.8 232600 4.3 31.78 -1.44 51.9 
Amelogenin R ATC AGA GCT TAA ACT GGG AAG CTG  CAG CTT CCC AGT TTA AGC TCT GAT  24 45.8 57 7425.9 241300 4.14 30.77 -2.71 49.1 
D1S1656 F GTG TTG CTC AAG GGT CAA CT AGT TGA CCC TTG AGC AAC AC 20 50 55.4 6148 189600 5.27 32.43 -1.53 37.4 
D1S1656 R GAG AAA TAG AAT CAC TAG GGA ACC  GGT TCC CTA GTG ATT CTA TTT CTC  24 41.7 52.6 7427.9 255400 3.92 29.08 -0.92 46.5 
D12S391 F ACA GGA TCA ATG GAT GCA TAG G CCT ATG CAT CCA TTG ATC CTG T 22 45.5 54.7 6832.5 230000 4.35 29.71 -0.5 32.9 
D12S391 R CAG CCT CCA TAT CAC TTG AGC  GCT CAA GTG ATA TGG AGG CTG  21 52.4 55.4 6326.2 192600 5.19 32.85 0.35 20.5 
D18S51 F TGA GTG ACA AAT TGA GAC CTT  AAG GTC TCA ATT TGT CAC TCA  21 38.1 51.7 6469.3 210100 4.76 30.79 0.18 21.4 
D18S51 R GTC TTA CAA TAA CAG TTG CTA CTA TT AAT AGT AGC AAC TGT TAT TGT AAG AC 26 30.8 51.2 7919.2 252300 3.96 31.39 -0.17 26.9 
FGA F AAT AAA ATT AGG CAT ATT TAC AAG CTA G CTA GCT TGT AAA TAT GCC TAA TTT TAT T 28 25 50.6 8627.7 295100 3.39 29.24 -0.2 27.8 
FGA R  GCT GCT GAG TGA TTT GTC TGT AAT TG CAA TTA CAG ACA AAT CAC TCA GCA GC 26 42.3 56.5 8038.2 244700 4.09 32.85 0.36 20.1 
rs1357617 F AGC TGA TGC AGA CCA CTT CAC  GTG AAG TGG TCT GCA TCA GCT  21 52.4 57.5 6375.2 199400 5.02 31.97 -1.3 41.5 
rs1357617 R GGA TAG CTG ATA AGA AAC ATG ACC A TGG TCA TGT TTC TTA TCA GCT ATC C 25 40 54.6 7732.1 264100 3.79 29.28 -1.62 53.5 
rs1029047 F CAT AAC GTG GAT TTG TCA GCA  TGC TGA CAA ATC CAC GTT ATG  21 42.9 53.3 6445.2 207500 4.82 31.06 0.13 23.2 
rs10290487 R GGA ATA AAC TGA AGG CTA AAG AAA AG CTT TTC TTT AGC CTT CAG TTT ATT CC 26 34.6 52.6 8118.4 284200 3.52 28.57 0.48 17.4 
rs763869 F ATC AAG TGC TTT CTG TTG ACA TTT G CAA ATG TCA ACA GAA AGC ACT TGA T 25 36 54.5 7653 234300 4.27 32.66 -0.17 26.9 
rs763869 R GGC TAC TCC CTC ATA ATG TAA TGC  GCA TTA CAT TAT GAG GGA GTA GCC  24 45.8 55.2 7287.8 225600 4.43 32.3 0.36 20.3 
rs735155 F GGA GAA AAC CGG AGA GCT G CAG CTC TCC GGT TTT CTC C 19 57.9 55.5 5935.9 199100 5.02 29.81 0.9 7 
rs735155 R GAG TGT CAC CGA ATT CAA CG CGT TGA ATT CGG TGA CAC TC 20 50 53.8 6126 197900 5.05 30.96 0.27 21.3 
rs729172 F CAT TAA TAT GAC CAA GGC TCC TCT  AGA GGA GCC TTG GTC ATA TTA ATG  24 41.7 54.4 7271.8 227100 4.4 32.02 0 25.1 
rs729172 R ACA TTT CCC TCT TGC GGT TAC  GTA ACC GCA AGA GGG AAA TGT  21 47.6 55.3 6323.1 185900 5.38 34.01 0.55 17 
MT-HV2 F GGT CTA TCA CCC TAT TAA CCA C GTG GTT AAT AGG GTG ATA GAC C 22 45.5 52.2 6614.4 206300 4.85 32.06 -0.41 31.3 
MT-HV2 R GCT TTG AGG AGG TAA GCT AC GTA GCT TAC CTC CTC AAA GC 20 50 52.7 6197.1 197900 5.05 31.31 -1.13 35.5 
